{
  "abstract": null,
  "abstract_shown": false,
  "affiliations": [
    "The Royal Marsden NHS Foundation Trust, London, England, UK",
    "3 Renal and Skin Units, The Royal Marsden NHS Foundation Trust, London, UK",
    "Cancer Science Institute of Singapore, National University of Singapore, Singapore",
    "8Singapore Immunology Network, Agency for Science, Singapore",
    "The Francis Crick Institute, London, UK",
    "The Francis Crick Institute, London, England, UK",
    "Cancer Research UK Manchester Institute, Manchester, England, UK"
  ],
  "article_type": null,
  "arxiv": null,
  "author_total": 13,
  "authors": [
    {
      "affs": [
        0
      ],
      "name": "James Larkin"
    },
    {
      "affs": [
        1
      ],
      "name": "Samra Turajlic"
    },
    {
      "affs": [
        2
      ],
      "name": "Teena Thakur"
    },
    {
      "affs": [
        3
      ],
      "name": "Kevin Mulder"
    },
    {
      "affs": [
        4
      ],
      "name": "Qingli Guo"
    },
    {
      "affs": [
        5
      ],
      "name": "Max Emmerich"
    },
    {
      "affs": [
        5
      ],
      "name": "Angelina Romanov"
    },
    {
      "affs": [
        0
      ],
      "name": "Laura Boddy"
    },
    {
      "affs": [
        6
      ],
      "name": "Marija Miletic"
    },
    {
      "affs": [
        0
      ],
      "name": "Kim Edmonds"
    },
    {
      "affs": [
        0
      ],
      "name": "Justine Korteweg"
    },
    {
      "affs": [
        4
      ],
      "name": "Anne-Laure Cattin"
    },
    {
      "affs": [
        4
      ],
      "name": "Stephanie Hepworth"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/ftzs3tnhch6n4.bib",
  "cited_by": 0,
  "doi": "10.1136/jitc-2026-sitc2026.0974",
  "fulltext_url": null,
  "id": "ftzs3tnhch6n4",
  "issns": [
    "2051-1426"
  ],
  "landing_url": "https://doi.org/10.1136/jitc-2026-sitc2026.0974",
  "language": "en",
  "licence": "CC-BY",
  "licence_label": "CC BY",
  "licence_source": "journal",
  "licence_url": "https://creativecommons.org/licenses/by/4.0/",
  "metadata_licence": null,
  "native_subjects": [
    [
      "lcc",
      "RC254-282"
    ],
    [
      "openalex",
      "2730|Cancer Immunotherapy and Biomarkers"
    ]
  ],
  "openalex": "W7225192890",
  "pdf_url": "https://jitc.bmj.com/content/14/Suppl_2/A1112.full.pdf",
  "pmcid": null,
  "pmid": null,
  "published": "2026-11-06",
  "publisher": "BMJ Publishing Group",
  "ris": "https://research.draconitic.com/paper/ftzs3tnhch6n4.ris",
  "sources": [
    {
      "first_seen": "2026-11-06T14:21:04Z",
      "native_id": "ca0303c9733a4893badcf3415f537624",
      "source": "doaj",
      "url": "https://doi.org/10.1136/jitc-2026-sitc2026.0974"
    }
  ],
  "subjects": [
    {
      "field": "medicine",
      "origin": "openalex:2730|Cancer Immunotherapy and Biomarkers",
      "subfield": "oncology"
    }
  ],
  "title": "974 Integrated multimodal profiling reveals conserved type II interferon signalling, ectopic lymphoid structure formation, and actionable inflammatory endotypes in cutaneous immune-related adverse events",
  "title_text": "974 Integrated multimodal profiling reveals conserved type II interferon signalling, ectopic lymphoid structure formation, and actionable inflammatory endotypes in cutaneous immune-related adverse events",
  "type": "peer-reviewed",
  "updated_at": "2026-11-08T14:20:17Z",
  "url": "https://research.draconitic.com/paper/ftzs3tnhch6n4",
  "venue": "Journal for ImmunoTherapy of Cancer",
  "versions": []
}